Intragraft levels of Foxp3 mRNA predict progression in renal transplants with borderline change

Journal of the American Society of Nephrology

Volumn 19, Issue 12, 2008, Pages 2277-2281

  Mansour, Hicham ^a   Homs, Sébastien ^a   Desvaux, Dominique ^a   Badoual, Cécile ^b   Dahan, Karine ^a   Matignon, Marie ^a   Audard, Vincent ^a   Lang, Philippe ^a   Grimbert, Philippe ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOSPORIN A; GAMMA INTERFERON; GRANZYME B; INTERLEUKIN 17; INTERLEUKIN 23; MESSENGER RNA; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; TRANSCRIPTION FACTOR FOXP3;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIAGNOSTIC ACCURACY; GENE EXPRESSION; GRAFT REJECTION; HISTOPATHOLOGY; HUMAN; KIDNEY BIOPSY; KIDNEY GRAFT; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

EID: 56249146391     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2008030254     Document Type: Article

References (19)

1. Solez K, Colvin RB, Racusen LC, Sis B, Halloran PF, Birk PE, Campbell PM, Cascalho M, Collins AB, Demetris AJ, Drachenberg CB, Gibson IW, Grimm PC, Haas M, Lerut E, Liapis H, Mannon RB, Marcus PB, Mengel M, Mihatsch MJ, Nankivell BJ, Nickeleit V, Papadimitriou JC, Platt JL, Randhawa P, Roberts I, Salinas-Madriga L, Salomon DR, Seron D, Sheaff M, Weening JJ: Banff '05 Meeting Report: Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 7: 518-526, 2007
2. Saad R, Gritsch HA, Shapiro R, Jordan M, Vivas C, Scantlebury V, Demetris AJ, Randhawa PS: Clinical significance of renal allograft biopsies with "borderline changes," as defined in the Banff Schema. Transplantation 64: 992-995, 1997
3. Schweitzer EJ, Drachenberg CB, Anderson L, Papadimetriou JC, Kuo PC, Johnson LB, Klassen DK, Hoehn-Saric E, Weir MR, Bartlett ST: Significance of the Banff borderline biopsy. Am J Kidney Dis 28: 585-588, 1996
4. Meehan SM, Siegel CT, Aronson AJ, Bartosh SM, Thistlethwaite JR, Woodle ES, Haas M: The relationship of untreated borderline infiltrates by the Banff criteria to acute rejection in renal allograft biopsies. J Am Soc Nephrol 10: 1806-1814, 1999
5. Mengel M, Sis B, Halloran PF: SWOT analysis of Banff: Strengths, weaknesses, opportunities and threats of the international Banff consensus process and classification system for renal allograft pathology. Am J Transplant 7: 2221-2226, 2007
6. Desvaux D, Schwarzinger M, Pastural M, Baron C, Abtahi M, Berrehar F, Lim A, Lang P, le Gouvello S: Molecular diagnosis of renal-allograft rejection: Correlation with histopathologic evaluation and antirejection-therapy resistance. Transplantation 78: 647-653, 2004
7. Grimbert P, Mansour H, Desvaux D, Roudot-Thoraval F, Audard V, Dahan K, Berrehar F, Dehoulle-Poillet C, Farcet JP, Lang P, Le Gouvello S: The regulatory/cytotoxic graft-infiltrating T cells differentiate renal allograft borderline change from acute rejection. Transplantation 83: 341-346, 2007
8. Muthukumar T, Dadhania D, Ding R, Snopkowski C, Naqvi R, Lee JB, Hartono C, Li B, Sharma VK, Seshan SV, Kapur S, Hancock WW, Schwartz JE, Suthanthiran M: Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med 353: 2342-2351, 2005
9. Kawai T, Cosimi AB, Spitzer TR, Tolkoff-Rubin N, Suthanthiran M, Saidman SL, Shaffer J, Preffer FI, Ding R, Sharma V, Fishman JA, Dey B, Ko DS, Hertl M, Goes NB, Wong W, Williams WW Jr, Colvin RB, Sykes M, Sachs DH: HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 358: 353-361, 2008
10. Annunziato F, Cosmi L, Santarlasci V, Maggi L, Liotta F, Mazzinghi B, Parente E, Fili L, Ferri S, Frosali F, Giudici F, Romagnani P, Parronchi P, Tonelli F, Maggi E, Romagnani S: Phenotypic and functional features of human Th17 cells. J Exp Med 204: 1849-1861, 2007
11. Hue S, Ahern P, Buonocore S, Kullberg MC, Cua DJ, McKenzie BS, Powrie F, Maloy KJ: Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J Exp Med 203: 2473-2483, 2006
12. Zheng Y, Danilenko DM, Valdez P, Kasman I, Eastham-Anderson J, Wu J, Ouyang W: Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445: 648-651, 2007
13. Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig MC, von Boehmer H: Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 6: 1219-1227, 2005
14. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK: Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238, 2006
15. Rush DN, Jeffery JR, Gough J: Sequential protocol biopsies in renal transplant patients: Clinico-pathological correlations using the Banff schema. Transplantation 59: 511-514, 1995
16. Seron D, Moreso F, Bover J, Condom E, Gil-Vernet S, Canas C, Fulladosa X, Torras J, Carrera M, Grinyo JM, Alsina J: Early protocol renal allograft biopsies and graft outcome. Kidney Int 51: 310-316, 1997
17. Gaber LW, Moore LW, Alloway RR, Flax SD, Shokouh-Amiri MH, Schroder T, Gaber AO: Correlation between Banff classification, acute renal rejection scores and reversal of rejection. Kidney Int 49: 481-487, 1996
18. Morrissey PE, Gohh R, Shaffer D, Crosson A, Madras PN, Sahyoun AI, Monaco AP: Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria. Transplantation 63: 845-848, 1997
19. Wang J, Ioan-Facsinay A, van der Voort EI, Huizinga TW, Toes RE: Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Eur J Immunol 37: 129-138, 2007